Eli Lilly

Healthcare

Novo Nordisk Takes Rival Eli Lilly to Court Over Weight-Loss Ad Claims

Photo via Jason Bergman/Sipa USA/Newscom

The Danish pharma giant alleged Lilly misled consumers with false advertising claims that its weight loss drug is superior to Novo’s.

2 min read

Photo via Kris Tripplaar/Sipa USA/Newscom

M&A

Eli Lilly to Pay up to $3.8B for AtaiBeckley in Big Pharma’s Latest Psychedelic Foray

The deal gives Eli Lilly access to a ⁠psychedelic-based nasal spray that studies show curbs treatment-resistant depression in a single dose.

1 min read
Photo via Spencer Jones/GHI//UCG/Universal Images Group/Newscom

Healthcare

Lilly Follows Upbeat Trials for Cholesterol Shot with $4B M&A Spree

The highest dose of a single injection reduced cholesterol levels by 62% in patients, according to Eli Lilly’s recently published study.

2 min read
Photo via Michael Siluk/UCG/Universal Images Group/Newscom

Healthcare

Scoring 2 Million Prescriptions, Novo’s GLP-1 Pill Crushes Expectations

The pill era has ushered in a Wild-West-style land-grab for GLP-1 market share but the horizon seems to keep expanding.

2 min read

Healthcare

Eli Lilly Invests Weight-Loss Windfall in Next-Gen Cancer Treatment

Photo via Gado Images/Smith Collection/Gado/Sipa USA/Newscom

Kelonia is developing a next-gen blood cancer treatment that’ll reprogram T-cells to help patients’ immune systems fight cancer.

2 min read

Healthcare

Eli Lilly Widens Access to Weight-Loss Injectable as Lower-Cost Pill Nears Approval

Photo via Gado Images/Smith Collection/Gado/Sipa USA/Newscom

Just 20% of firms with 200 or more workers said they covered GLP-1 drugs for weight loss, according to the Peterson-KFF Health System Tracker.

2 min read

Healthcare

Oh no, Ozempic! Eli Lilly’s New Weight-Loss Drug KOs Rival Treatments

Photo via Gado Images/Smith Collection/Gado/Sipa USA/Newscom

The company also said earlier this week it will drop $6 billion on a new manufacturing facility in Huntsville, Alabama.

2 min read

Sign Up for The Daily Upside to Unlock This Article

Sharp news & analysis on finance, economics, and investing.